Online reports that Sarborg Limited, an AI-driven drug development technology company, announced the completion of a US$10 million seed round of financing, led by Corvus Capital. The company plans to use the new funds to expand AI agents, cybernetic algorithms and machine learning capabilities in other industry areas, and explore equity, tokenized securities and cryptocurrency-based blockchain technology in multiple verticals.